Trials / Withdrawn
WithdrawnNCT04898036
Phototherapy For Treatment Of Raynaud's Phenomenon
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To determine if blue light therapy can improve the symptoms of Raynaud's phenomenon, and provide parameters for ultimately designing commercial treatment devices, an investigational stationary phototherapy unit was designed and built.
Detailed description
The purpose of this study is to test the efficacy of blue light phototherapy for the treatment of Raynaud's phenomenon (RP) in human participants. The specific aim is to see if phototherapy treatment applied to the hands will reduce the symptoms that RP participants experience. This will be measured through the use of a visual analog scale (VAS) of both pain and numbness. This study will also help to infer whether blue light phototherapy causes vasodilation through infrared thermal imaging of the hands and continuous measurement of skin temperature with a surface thermistor. Together, the visual analog scale (VAS) and infrared thermal imaging contribute to the objective of deducing whether blue light phototherapy can lead to reduced RP symptoms due to vasodilation of blood vessels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Blue Light Therapy | This phototherapy device (PTD-1) consists of a Plexiglas hand compartment (cleanable) enclosed in a powder-coated steel cabinet. Within the cabinet are two blue LED panels located above and below the hand compartment to illuminate the hands. |
| DEVICE | Sham Light Therapy | To turn the device into a sham mode, a thin opaque liner can be inserted which will block light from illuminating the hands. |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2021-05-24
- Last updated
- 2023-01-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04898036. Inclusion in this directory is not an endorsement.